Superfund Technical Assessment and Response Team Contract Solicitation

EPA Region 9 Contracting Office issued a Combined Synopsis/Solicitation for Superfund Technical Assessment and Response Team (START) services to support On-Scene Coordinators implementing the National Response System. The opportunity is set aside for total small business under NAICS 541620. Offers are due April 27, 2026.

Vidal v. Venettozzi - Prison Disciplinary Due Process

The Second Circuit vacated the Southern District of New York's grant of summary judgment to DOCCS officials in an inmate's due process challenge. The court held that 270 days of disciplinary segregation (served: 180 days) constitutes an atypical and significant hardship triggering Fourteenth Amendment procedural protections. The case was remanded for further proceedings consistent with this opinion.

Second Circuit appellate decision in Waldman v. PLO case

Second Circuit appellate decision in Waldman v. PLO case

Patrick Rhode Sworn In as PUCT Commissioner

Patrick Rhode was sworn in as Commissioner of the Public Utility Commission of Texas (PUCT) on April 2, 2026. He was appointed by Governor Greg Abbott effective April 1, 2026. His background includes service as Special Assistant to the President of the United States, NASA Senior Advisor, senior roles at the Department of Homeland Security, and Vice President of an international infrastructure company.

VYLOY Regulatory Review Period Determination for Patent Extension

The FDA has determined the regulatory review period for VYLOY, a human biological product, as required by law for patent extension purposes. The notice solicits public comments on the accuracy of the published dates and allows interested parties to petition FDA regarding whether the applicant acted with due diligence during the review period. Comments on date accuracy are due June 2, 2026, and due diligence petitions are due September 30, 2026.

Determination of Regulatory Review Period for VYLOY Patent Extension

FDA has determined the regulatory review period for VYLOY, a human biological product, as required by law for patent extension purposes. The Agency is publishing this notice to allow interested parties to comment on the determination or petition for redetermination regarding due diligence. Multiple patent extension applications (FDA-2025-E-0845 through FDA-2025-E-0872) are included in this notice.

VYLOY Patent Extension Regulatory Review Period Determination

FDA has determined the regulatory review period for VYLOY, a human biological product, and is publishing this determination as required by law for patent term extension applications. Interested parties may submit comments on the dates or petition FDA regarding due diligence. Comment deadline is June 2, 2026, and petition deadline is September 30, 2026.

Tobacco Product Citizen Complaint

FDA Center for Tobacco Products received and closed a citizen complaint (FDA-2026-H-3165) for comments. The complaint is now in closed status with no documents available for public review. No regulatory action or compliance requirements identified.

FDA Complaint Filed with Center for Tobacco Products

FDA Center for Tobacco Products filed a complaint under docket FDA-2026-H-3164-0001. The complaint has been closed for comments, indicating the administrative filing process is complete. No documents are available for public review at this time.

Determination of Regulatory Review Period for ZIIHERA

FDA has determined the regulatory review period for ZIIHERA, a human biological product, as required by law for patent extension calculations. The notice invites comments on the determination and sets deadlines for challenges. Interested parties may submit comments by June 2, 2026, and petitions regarding due diligence by September 30, 2026.